|
DE10262084B4
|
|
Protective solution for the prevention of ischemic damage
|
|
ES2058023A1
|
|
Derivatives of the acid 4-hidroxi-butirico.
|
|
EP0487981A1
|
|
Container for solutions for infusion, perfusion and/or comparable clinical/medical procedures
|
|
DE4113984A1
|
|
Salts of 4-hydroxy butyric acid
|
|
DE4109169A1
|
|
WATER-SOLUBLE NON-IONIC X-RAY CONTRASTING AGENTS AND AGENTS AND METHOD FOR THE PRODUCTION THEREOF
|
|
DE3726721A1
|
|
USE OF A CALCIUM CHELATE OF ETHANOLAMINOPHOSPHORIC ACID FOR PROPHYLAXIS OR THERAPY
|
|
ES8800892A1
|
|
N,N-di:acetamido tri:iodo-benzoyl sarcosyl N-methyl glucamide prepn.
|
|
DE3407473A1
|
|
WATER-SOLUBLE 3,5-DIACETAMIDO-2,4,6-TRIIODBENZOESAE DERIVATIVES AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
DE3300137A1
|
|
AGENTS FOR PROMOTING PROTEIN SYNTHESIS IN ANIMALS
|
|
EP0054635A1
|
|
Protective solution for heart and kidney, and manufacturing process
|
|
EP0053244A1
|
|
Composition for preventing EPH gestosis and other disturbances of the metabolism during pregnancy
|
|
EP0051163A2
|
|
A 4-dimethylaminophenol-hydrochloride solution for painless intramuscular administration, and process for its preparation
|
|
DE3134050A1
|
|
Solution for sterilising and removing pyrogens from stainless steel lines and filters in a closed system
|
|
EP0012272A1
|
|
Protecting solution for heart and kidneys and process for its manufacture
|
|
DE2851037B1
|
|
Process for the stabilization of sodium thiosulfate solutions intended for medical purposes
|
|
DE2507955A1
|
|
Stabilisation of aq. 4-dimethyl-amino-phenol solns. - with physiologically compatible reducing agent in low concn. for long-term storage
|
|
DE2216000A1
|
|
MEDICINAL PRODUCTS FOR THERAPEUTIC USE IN DERMATOLOGY AND SURGERY
|
